MNPR (MNPR) Stock Price & Analysis
MNPR (MNPR) fell 0.83% to USD 117.56 as of September 8, 2026 at 06:20 UTC, according to Nexqual real-time market data.
MNPR last closed at USD 117.56; the session ranged USD 116.21–119 on volume of 82,245 shares. Market capitalization is —, with a 52-week range of USD 41.67–124.82 (NCM). Source: Nexqual, September 8, 2026 at 06:20 UTC.
Key Statistics (as of September 8, 2026 at 06:20 UTC)
| Price | USD 117.56 |
|---|---|
| Change | ▼ 0.83% (down) |
| Previous Close | USD 117.56 |
| Open | USD 117.56 |
| Day Range | USD 116.21 – 119 |
| 52-Week Range | USD 41.67 – 124.82 |
| Volume | 82,245 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (MNPR)
Nexqual's technical model rates MNPR "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 06:20 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 54.19 (neutral) |
| vs SMA50 | Above (USD 109.57) |
| MACD | 2.23 (positive) |
From MNPR's Latest SEC 10-K Filing (filed 2026-03-27)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BCDA | BioCardia, Inc. | USD 1.08 | ▼ 2.7% |
| NMAD | Nomad Power Solutions, Inc. | USD 4.03 | ▲ 8.63% |
| PBLA | Panbela Therapeutics, Inc. | USD 0 | ▲ 0% |
| ZVSA | ZyVersa Therapeutics, Inc. | USD 0.1 | ▲ 4.04% |
| KZIA | Kazia Therapeutics Limited | USD 12.31 | ▼ 2.38% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:20 UTC. This page is informational and not investment advice.